• Therapeutic Solutions International Launches Clinical Trial to Validate First Blood Based Predicator of Suicidal Ideation: The Campbell Score

    1 month ago - By San Diego Biotechnology

    Clinical Stage Biotech Company Aims to Develop Biology Based Means of Assessing Suicide Risk and Providing Immunotherapy Based Interventions
    OCEANSIDE, Calif., Oct. 29, 2020 /PRNewswire/ - Therapeutics Solution International, Inc., (OTC Markets: TSO......
    Read more ...